Showing 1 - 20 results of 333 for search '"NINDS"', query time: 0.14s Refine Results
  1. 1
  2. 2

    Pathogenic Ischemic Stroke Phenotypes in the NINDS-Stroke Genetics Network. by Ay, H, Arsava, E, Andsberg, G, Benner, T, Brown, R, Chapman, SN, Cole, J, Delavaran, H, Dichgans, M, Engström, G, Giralt-Steinhauer, E, Grewal, R, Gwinn, K, Jern, C, Jimenez-Conde, J, Jood, K, Katsnelson, M, Kissela, B, Kittner, S, Kleindorfer, DO, Labovitz, D, Lanfranconi, S, Lee, J, Lehm, M, Lemmens, R

    Published 2014
    “…BACKGROUND AND PURPOSE: NINDS (National Institute of Neurological Disorders and Stroke)-SiGN (Stroke Genetics Network) is an international consortium of ischemic stroke studies that aims to generate high-quality phenotype data to identify the genetic basis of pathogenic stroke subtypes. …”
    Journal article
  3. 3
  4. 4
  5. 5
  6. 6

    Validation of NINDS-VCI Neuropsychology Protocols for Vascular Cognitive Impairment in Taiwan. by Hsiu-Fen Lin, Chang-Ming Chern, Hui-Mei Chen, Yi-Chun Yeh, Shu-Chih Yao, Mei-Feng Huang, Shuu-Jiun Wang, Cheng-Sheng Chen, Jong-Ling Fuh

    Published 2016-01-01
    “…Clinical diagnosis of VCI was made. The NINDS-VCI Neuropsychology Protocols, 60-, 30-, and two 5-minute protocols, were administered. …”
    Get full text
    Article
  7. 7

    Risk of selection bias assessment in the NINDS rt-PA stroke study by Ravi Garg, Steffen Mickenautsch

    Published 2022-06-01
    “…Abstract Objectives The NINDS rt-PA Stroke Study is frequently cited in support of alteplase for acute ischemic stroke within 3 h of symptom onset. …”
    Get full text
    Article
  8. 8

    Introduction: Inequality in Education – Innovation in Methods, with reflections by Dr Nicola Ingram and Professor Melanie Nind by Carli Ria Rowell, Siobhan Dytham, Nicola Ingram, Melanie Nind

    Published 2015-04-01
    “…This article introduces this featured section, including reflections from Dr Nicola Ingram and Professor Melanie Nind, who both delivered keynote addresses at the conference.…”
    Get full text
    Article
  9. 9
  10. 10

    Antiepileptogenesis and disease modification: Progress, challenges, and the path forward—Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modification workshop by Aristea S. Galanopoulou, Wolfgang Löscher, Laura Lubbers, Terence J. O’Brien, Kevin Staley, Annamaria Vezzani, Raimondo D’Ambrosio, H. Steve White, Harald Sontheimer, John A. Wolf, Roy Twyman, Vicky Whittemore, Karen S. Wilcox, Brian Klein

    Published 2021-06-01
    “…In 2018, the National Institute of Neurological Disease and Stroke (NINDS) convened a workshop titled “Accelerating the Development of Therapies for Antiepileptogenesis and Disease Modification” that brought together preclinical and clinical investigators and industry and regulatory bodies’ representatives to discuss and propose a roadmap to accelerate the development of antiepileptogenic (AEG) and disease‐modifying (DM) new therapies. …”
    Get full text
    Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20